|
Market Closed -
Nasdaq
04:00:00 29/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 2.020 USD | -3.35% |
|
-3.35% | +47.45% |
| 08-13 | Allogene Therapeutics Remains Attractive Given Valuation, Clinical Strategy, RBC Says | MT |
| 08-13 | Allogene Therapeutics, Inc., Q2 2026 Earnings Call, Aug 12, 2026 |
| Market Cap | 698M 601M 564M 515M 970M 66.7B 973M 6.69B 2.61B 33.67B 2.62B 2.56B 112B | P/E 2026 * |
-3.35x | P/E 2027 * | -3.15x |
|---|---|---|---|---|---|
| Enterprise Value | 501M 432M 405M 370M 697M 47.92B 699M 4.81B 1.88B 24.19B 1.88B 1.84B 80.21B | EV / Sales 2026 * |
147x | EV / Sales 2027 * | 45.3x |
| Free-Float |
83.55% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Allogene Therapeutics, Inc.
| 1 day | -3.35% | ||
| 1 week | -3.35% | ||
| Current month | +7.45% | ||
| 1 month | +11.60% | ||
| 3 months | -6.91% | ||
| 6 months | -27.34% | ||
| Current year | +47.45% |
| 1 week | 2 |  | 2.21 |
| 1 month | 1.81 | | 2.23 |
| Current year | 1.31 | | 4.46 |
| 1 year | 1.04 | | 4.46 |
| 3 years | 0.86 | | 5.78 |
| 5 years | 0.86 | | 27.86 |
| 10 years | 0.86 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Zachary Roberts
CEO | Chief Executive Officer | 48 | 01/07/2026 |
Geoffrey Parker
DFI | Director of Finance/CFO | 61 | 16/10/2023 |
Benjamin Beneski
CTO | Chief Tech/Sci/R&D Officer | 49 | 28/02/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Arie Belldegrun
CHM | Chairman | 76 | 01/11/2017 |
David Chang
BRD | Director/Board Member | 66 | 01/06/2018 |
Joshua Kazam
BRD | Director/Board Member | 49 | 01/11/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 21/8/26 | Sell | Compliance Officer | -29,697 | 0.0086% | ||
| 1/7/26 | Free | Chief Executive Officer | 610,720 | 0.1769% | ||
| 18/6/26 | Free | Director | 95,400 | 0.0276% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.35% | -3.35% | +78.76% | -47.40% | 698M | |
| -1.59% | -3.35% | +52.37% | +93.70% | 69.54B | |
| -1.34% | -0.75% | +48.21% | +91.86% | 64.97B | |
| +0.30% | -0.69% | +52.56% | +10.23% | 26.51B | |
| -2.35% | -5.75% | -12.90% | +448.54% | 25.89B | |
| -8.37% | -12.43% | +2.08% | -16.71% | 25.64B | |
| -0.96% | +10.36% | +283.06% | +436.50% | 20.22B | |
| -0.51% | +0.23% | +35.77% | -18.70% | 19.98B | |
| -1.91% | -4.37% | +13.28% | +535.19% | 15.69B | |
| -1.47% | +0.68% | +45.51% | +143.08% | 13.49B | |
| Average | -2.16% | -2.07% | +59.87% | +167.63% | 28.26B | |
| Weighted average by Cap. | -1.93% | -1.51% | +53.79% | +151.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.4M 2.93M 2.75M 2.51M 4.72M 325M 4.74M 32.59M 12.72M 164M 12.77M 12.49M 544M | 12.09M 10.41M 9.76M 8.91M 16.79M 1.16B 16.85M 116M 45.2M 583M 45.38M 44.39M 1.93B |
| Net income | -185M -160M -150M -137M -257M -17.69B -258M -1.77B -692M -8.93B -695M -680M -29.62B | -220M -189M -178M -162M -305M -21.01B -306M -2.11B -822M -10.61B -825M -807M -35.17B |
| Net Debt | -197M -169M -159M -145M -273M -18.78B -274M -1.88B -735M -9.48B -738M -722M -31.44B | -150M -129M -121M -111M -209M -14.35B -209M -1.44B -562M -7.24B -564M -552M -24.02B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | US$2.020 | -3.35% | 3,824,689 |
| 27/08/26 | US$2.090 | +2.45% | 4,982,882 |
| 26/08/26 | US$2.040 | -5.99% | 5,020,715 |
| 25/08/26 | US$2.170 | +6.90% | 6,156,769 |
| 24/08/26 | US$2.030 | -2.87% | 4,755,951 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALLO Stock
Select your edition
All financial news and data tailored to specific country editions
